vs
纽约梅隆银行（BK）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是纽约梅隆银行的1.1倍（$1.4B vs $1.3B），纽约梅隆银行净利率更高（108.5% vs 27.6%，领先81.0%），纽约梅隆银行同比增速更快（12.7% vs 11.0%），纽约梅隆银行自由现金流更多（$4.7B vs $311.2M），过去两年纽约梅隆银行的营收复合增速更高（13.8% vs 9.0%）
纽约梅隆银行是总部位于美国纽约的全球性金融服务机构，2007年7月由纽约银行与梅隆金融公司合并组建而成，业务覆盖全球众多市场，为机构、企业及个人客户提供专业金融服务，在资产管理、证券服务等领域拥有领先的行业地位。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
BK vs RMD — 直观对比
营收规模更大
RMD
是对方的1.1倍
$1.3B
营收增速更快
BK
高出1.8%
11.0%
净利率更高
BK
高出81.0%
27.6%
自由现金流更多
BK
多$4.4B
$311.2M
两年增速更快
BK
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.4B |
| 净利润 | $1.5B | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | — | 34.6% |
| 净利率 | 108.5% | 27.6% |
| 营收同比 | 12.7% | 11.0% |
| 净利润同比 | 26.5% | 13.9% |
| 每股收益（稀释后） | $2.01 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKRMD
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.0B | $1.2B | ||
| Q2 24 | $1.0B | $1.2B | ||
| Q1 24 | $1.0B | $1.2B |
净利润BKRMD
| Q4 25 | $1.5B | $392.6M | ||
| Q3 25 | $1.4B | $348.5M | ||
| Q2 25 | $1.4B | $379.7M | ||
| Q1 25 | $1.2B | $365.0M | ||
| Q4 24 | $1.2B | $344.6M | ||
| Q3 24 | $1.2B | $311.4M | ||
| Q2 24 | $1.2B | $292.2M | ||
| Q1 24 | $1.0B | $300.5M |
毛利率BKRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率BKRMD
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 33.7% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率BKRMD
| Q4 25 | 108.5% | 27.6% | ||
| Q3 25 | 116.9% | 26.1% | ||
| Q2 25 | 118.3% | 28.2% | ||
| Q1 25 | 105.3% | 28.3% | ||
| Q4 24 | 96.7% | 26.9% | ||
| Q3 24 | 112.8% | 25.4% | ||
| Q2 24 | 113.4% | 23.9% | ||
| Q1 24 | 98.6% | 25.1% |
每股收益（稀释后）BKRMD
| Q4 25 | $2.01 | $2.68 | ||
| Q3 25 | $1.88 | $2.37 | ||
| Q2 25 | $1.93 | $2.58 | ||
| Q1 25 | $1.58 | $2.48 | ||
| Q4 24 | $1.53 | $2.34 | ||
| Q3 24 | $1.50 | $2.11 | ||
| Q2 24 | $1.52 | $1.97 | ||
| Q1 24 | $1.25 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1B | $1.4B |
| 总债务越低越好 | $31.9B | $403.9M |
| 股东权益账面价值 | $44.3B | $6.3B |
| 总资产 | $472.3B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.72× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资BKRMD
| Q4 25 | $5.1B | $1.4B | ||
| Q3 25 | $5.1B | $1.4B | ||
| Q2 25 | $5.7B | $1.2B | ||
| Q1 25 | $5.4B | $932.7M | ||
| Q4 24 | $4.2B | $521.9M | ||
| Q3 24 | $6.2B | $426.4M | ||
| Q2 24 | $5.3B | $238.4M | ||
| Q1 24 | $5.3B | $237.9M |
总债务BKRMD
| Q4 25 | $31.9B | $403.9M | ||
| Q3 25 | $32.3B | $408.7M | ||
| Q2 25 | $33.4B | $658.4M | ||
| Q1 25 | $30.9B | $663.1M | ||
| Q4 24 | $30.9B | $662.9M | ||
| Q3 24 | $33.2B | $667.6M | ||
| Q2 24 | $30.9B | $697.3M | ||
| Q1 24 | $32.4B | $997.0M |
股东权益BKRMD
| Q4 25 | $44.3B | $6.3B | ||
| Q3 25 | $43.9B | $6.1B | ||
| Q2 25 | $44.0B | $6.0B | ||
| Q1 25 | $43.1B | $5.5B | ||
| Q4 24 | $41.3B | $5.3B | ||
| Q3 24 | $42.0B | $5.2B | ||
| Q2 24 | $40.8B | $4.9B | ||
| Q1 24 | $40.6B | $4.6B |
总资产BKRMD
| Q4 25 | $472.3B | $8.5B | ||
| Q3 25 | $455.3B | $8.3B | ||
| Q2 25 | $485.8B | $8.2B | ||
| Q1 25 | $440.7B | $7.6B | ||
| Q4 24 | $416.1B | $7.1B | ||
| Q3 24 | $427.5B | $7.2B | ||
| Q2 24 | $428.5B | $6.9B | ||
| Q1 24 | $434.7B | $6.8B |
负债/权益比BKRMD
| Q4 25 | 0.72× | 0.06× | ||
| Q3 25 | 0.74× | 0.07× | ||
| Q2 25 | 0.76× | 0.11× | ||
| Q1 25 | 0.72× | 0.12× | ||
| Q4 24 | 0.75× | 0.13× | ||
| Q3 24 | 0.79× | 0.13× | ||
| Q2 24 | 0.76× | 0.14× | ||
| Q1 24 | 0.80× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $4.7B | $311.2M |
| 自由现金流率自由现金流/营收 | 352.8% | 21.9% |
| 资本支出强度资本支出/营收 | 32.4% | 2.0% |
| 现金转化率经营现金流/净利润 | 3.55× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $5.2B | $1.8B |
8季度趋势，按日历期对齐
经营现金流BKRMD
| Q4 25 | $5.2B | $339.7M | ||
| Q3 25 | $-1.1B | $457.3M | ||
| Q2 25 | $2.2B | $538.8M | ||
| Q1 25 | $412.0M | $578.7M | ||
| Q4 24 | $1.6B | $308.6M | ||
| Q3 24 | $-312.0M | $325.5M | ||
| Q2 24 | $2.1B | $440.1M | ||
| Q1 24 | $-2.7B | $402.0M |
自由现金流BKRMD
| Q4 25 | $4.7B | $311.2M | ||
| Q3 25 | $-1.5B | $414.4M | ||
| Q2 25 | $1.8B | $508.2M | ||
| Q1 25 | $92.0M | $557.9M | ||
| Q4 24 | $1.1B | $288.0M | ||
| Q3 24 | $-687.0M | $307.7M | ||
| Q2 24 | $1.7B | $415.2M | ||
| Q1 24 | $-3.0B | $380.8M |
自由现金流率BKRMD
| Q4 25 | 352.8% | 21.9% | ||
| Q3 25 | -121.5% | 31.0% | ||
| Q2 25 | 152.8% | 37.7% | ||
| Q1 25 | 7.9% | 43.2% | ||
| Q4 24 | 95.2% | 22.5% | ||
| Q3 24 | -65.6% | 25.1% | ||
| Q2 24 | 169.6% | 33.9% | ||
| Q1 24 | -286.4% | 31.8% |
资本支出强度BKRMD
| Q4 25 | 32.4% | 2.0% | ||
| Q3 25 | 35.4% | 3.2% | ||
| Q2 25 | 29.8% | 2.3% | ||
| Q1 25 | 27.6% | 1.6% | ||
| Q4 24 | 34.6% | 1.6% | ||
| Q3 24 | 35.8% | 1.5% | ||
| Q2 24 | 37.1% | 2.0% | ||
| Q1 24 | 28.7% | 1.8% |
现金转化率BKRMD
| Q4 25 | 3.55× | 0.87× | ||
| Q3 25 | -0.74× | 1.31× | ||
| Q2 25 | 1.54× | 1.42× | ||
| Q1 25 | 0.34× | 1.59× | ||
| Q4 24 | 1.34× | 0.90× | ||
| Q3 24 | -0.26× | 1.05× | ||
| Q2 24 | 1.82× | 1.51× | ||
| Q1 24 | -2.61× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BK
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
